Results 51 to 60 of about 52,946 (303)
Trends in gabapentinoid prescribing: A nationwide Danish drug utilization study
British Journal of Clinical Pharmacology, EarlyView.Aims Pregabalin and gabapentin are increasingly used for pain and other conditions. Concerns exist about overuse as well as potential misuse and abuse. To guide rational prescribing practices, we provide detailed nationwide data on the use of gabapentinoids in Denmark.
Anton Pottegård +7 more
wiley +1 more source
Clinical Observation of Olanzapine in Treatment of Nausea and Vomiting Caused by Opioid Analgesics
Zhongliu Fangzhi Yanjiu, 2018 Objective To observe the efficacy and side effects of olanzapine in the treatment of nausea and vomiting caused by opioid analgesics in cancer patients.
LI Daojun +3 more
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims To develop an evidence‐ and consensus‐based patient prioritization tool for use by UK mental health inpatient pharmacy teams. Methods A modified‐Delphi technique was used to obtain experts' agreement on the content, design and practical use of the patient prioritization tool.
Fatima Q. Alshaikhmubarak +3 more
wiley +1 more source
Prescription drug use in breastfeeding mothers and infant exposure: A register‐based cohort study
British Journal of Clinical Pharmacology, EarlyView.Abstract Aims Breast milk is the optimal infant nutrition; however, many infants may be exposed to prescription drugs if used by their mothers during breastfeeding. The aim of this study was to evaluate the prevalence and patterns of prescription drug use among breastfeeding mothers and to assess the availability of relative infant dose information for
Ditte Resendal Gotfredsen +5 more
wiley +1 more source
A new extended release formulation (OROS®) of hydromorphone in the management of pain
Therapeutics and Clinical Risk Management, 2008 Sharon M WeinsteinUniversity of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USAAbstract: Opioid analgesics are essential in the treatment of moderate to severe cancer-related pain.
Sharon M Weinstein
doaj
Swiss Medical WeeklyOBJECTIVE: To investigate claims patterns for metamizole and other non-opioid analgesics in Switzerland. To characterise users of these non-opioid analgesics regarding sex, age, comedications and canton of residence.
Stephan Gut +7 more
doaj +1 more source
Non-opioid analgesic poisoning [PDF]
Clinical Medicine, 2003 L'abus medicamenteux des antiinflammatoires, du paracetamol et de l'aspirine est tres important dans de nombreux pays ...
Glyn Volans +3 more
openaire +3 more sources
British Journal of Clinical Pharmacology, EarlyView.Aims In 2013, risk minimization measures (RMMs) were introduced in Europe to address the increased cardiovascular risk linked to diclofenac. This study aimed to assess the impact of those RMMs on analgesic use. Methods Primary care data from CPRD GOLD (UK) were used.
Tomas Lasys +5 more
wiley +1 more source
Clinically important drug interactions with opioid and non-opioid analgesics [PDF]
Arhiv za farmaciju, 2019 Patients often seek advise from doctors and pharmacists about pain treatment. Opioid and non-opioid analgesics are the most commonly used drugs in the treatment of pain, but they have potential for pharmacodynamic and pharmacokinetic drug-drug ...
Vezmar-Kovačević Sandra +4 more
doaj